Economics and Mathematical Modeling in Health-Related Research
portes grátis
Economics and Mathematical Modeling in Health-Related Research
Ciecierski, Christina; Weresa, Marzenna; Filus, Lidia
Brill
09/2022
218
Dura
Inglês
9789004512122
15 a 20 dias
1
Descrição não disponível.
Acknowledgement
List of Figures and Tables
Introduction
?Marzenna Anna Weresa, Christina Ciecierski and Lidia Filus
PART 1: Modeling of Diseases' Risk Factors: Implications for Patients' Treatment
1 Racial, Ethnic and Socioeconomic Disparities in Lung and Breast Cancer Outcomes
?Joe Feinglass
2 Reducing Cancer Mortality: A Cluster Analysis of Risk Factors for Lung Cancer across EU Countries
?Dawid Majcherek, Marzenna Anna Weresa and Christina Ciecierski
3 Trends in Incidence of Zoonotic Foodborne Diseases in the United States in 2010-2019
?Sayansk Da Silva and Joseph E. Hibdon, Jr.
PART 2: Determinants of Public Health Outcomes
4 Institutional Analysis of Healthcare Systems in Selected Developed Countries
?Julian Smolka
5 Value Based Healthcare (VBHC) as a Tool for Achieving Clinical Effectiveness
?Ewelina Nojszewska and Agata Sielska
6 Meeting Grand Challenges: Assessment of Horizon 2020 Health, Demographic Change and Wellbeing Projects
?Malgorzata Stefania Lewandowska
7 Bank Density, Population Density, and Economic Deprivation across the United States: Implications for Public Health Outcomes
?Scott W. Hegerty
PART 3: Pharmaceutical Industry: Innovation, Trade, and Company Performance
8 Healthcare Systems and Pharmaceutical Industry in Emerging and Developed Economies: China and Poland versus the US and the EU
?Arkadiusz Michal Kowalski
9 Export Patterns in Medical Products in the Times of the Covid-19 Pandemic: Focus on Pharmaceuticals
?Marzenna Anna Weresa
10 Pharmaceutical Companies as Portfolio Investments
?Izabela Pruchnicka-Grabias
Conclusions
?Marzenna Anna Weresa, Christina Ciecierski and Lidia Filus
Index
List of Figures and Tables
Introduction
?Marzenna Anna Weresa, Christina Ciecierski and Lidia Filus
PART 1: Modeling of Diseases' Risk Factors: Implications for Patients' Treatment
1 Racial, Ethnic and Socioeconomic Disparities in Lung and Breast Cancer Outcomes
?Joe Feinglass
2 Reducing Cancer Mortality: A Cluster Analysis of Risk Factors for Lung Cancer across EU Countries
?Dawid Majcherek, Marzenna Anna Weresa and Christina Ciecierski
3 Trends in Incidence of Zoonotic Foodborne Diseases in the United States in 2010-2019
?Sayansk Da Silva and Joseph E. Hibdon, Jr.
PART 2: Determinants of Public Health Outcomes
4 Institutional Analysis of Healthcare Systems in Selected Developed Countries
?Julian Smolka
5 Value Based Healthcare (VBHC) as a Tool for Achieving Clinical Effectiveness
?Ewelina Nojszewska and Agata Sielska
6 Meeting Grand Challenges: Assessment of Horizon 2020 Health, Demographic Change and Wellbeing Projects
?Malgorzata Stefania Lewandowska
7 Bank Density, Population Density, and Economic Deprivation across the United States: Implications for Public Health Outcomes
?Scott W. Hegerty
PART 3: Pharmaceutical Industry: Innovation, Trade, and Company Performance
8 Healthcare Systems and Pharmaceutical Industry in Emerging and Developed Economies: China and Poland versus the US and the EU
?Arkadiusz Michal Kowalski
9 Export Patterns in Medical Products in the Times of the Covid-19 Pandemic: Focus on Pharmaceuticals
?Marzenna Anna Weresa
10 Pharmaceutical Companies as Portfolio Investments
?Izabela Pruchnicka-Grabias
Conclusions
?Marzenna Anna Weresa, Christina Ciecierski and Lidia Filus
Index
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
America; E.U.; EU; European Union; Poland; U.S.; US; United States; cancer; cancer epidemiology; epidemiology; food; food safety; healthcare; healthcare system; medical products; pharmaceutical; pharmaceutical industry; pharmaceutics; public health; risk factors for cancer; safety; social determinants of health; zoonotic; zoonotic diseases
Acknowledgement
List of Figures and Tables
Introduction
?Marzenna Anna Weresa, Christina Ciecierski and Lidia Filus
PART 1: Modeling of Diseases' Risk Factors: Implications for Patients' Treatment
1 Racial, Ethnic and Socioeconomic Disparities in Lung and Breast Cancer Outcomes
?Joe Feinglass
2 Reducing Cancer Mortality: A Cluster Analysis of Risk Factors for Lung Cancer across EU Countries
?Dawid Majcherek, Marzenna Anna Weresa and Christina Ciecierski
3 Trends in Incidence of Zoonotic Foodborne Diseases in the United States in 2010-2019
?Sayansk Da Silva and Joseph E. Hibdon, Jr.
PART 2: Determinants of Public Health Outcomes
4 Institutional Analysis of Healthcare Systems in Selected Developed Countries
?Julian Smolka
5 Value Based Healthcare (VBHC) as a Tool for Achieving Clinical Effectiveness
?Ewelina Nojszewska and Agata Sielska
6 Meeting Grand Challenges: Assessment of Horizon 2020 Health, Demographic Change and Wellbeing Projects
?Malgorzata Stefania Lewandowska
7 Bank Density, Population Density, and Economic Deprivation across the United States: Implications for Public Health Outcomes
?Scott W. Hegerty
PART 3: Pharmaceutical Industry: Innovation, Trade, and Company Performance
8 Healthcare Systems and Pharmaceutical Industry in Emerging and Developed Economies: China and Poland versus the US and the EU
?Arkadiusz Michal Kowalski
9 Export Patterns in Medical Products in the Times of the Covid-19 Pandemic: Focus on Pharmaceuticals
?Marzenna Anna Weresa
10 Pharmaceutical Companies as Portfolio Investments
?Izabela Pruchnicka-Grabias
Conclusions
?Marzenna Anna Weresa, Christina Ciecierski and Lidia Filus
Index
List of Figures and Tables
Introduction
?Marzenna Anna Weresa, Christina Ciecierski and Lidia Filus
PART 1: Modeling of Diseases' Risk Factors: Implications for Patients' Treatment
1 Racial, Ethnic and Socioeconomic Disparities in Lung and Breast Cancer Outcomes
?Joe Feinglass
2 Reducing Cancer Mortality: A Cluster Analysis of Risk Factors for Lung Cancer across EU Countries
?Dawid Majcherek, Marzenna Anna Weresa and Christina Ciecierski
3 Trends in Incidence of Zoonotic Foodborne Diseases in the United States in 2010-2019
?Sayansk Da Silva and Joseph E. Hibdon, Jr.
PART 2: Determinants of Public Health Outcomes
4 Institutional Analysis of Healthcare Systems in Selected Developed Countries
?Julian Smolka
5 Value Based Healthcare (VBHC) as a Tool for Achieving Clinical Effectiveness
?Ewelina Nojszewska and Agata Sielska
6 Meeting Grand Challenges: Assessment of Horizon 2020 Health, Demographic Change and Wellbeing Projects
?Malgorzata Stefania Lewandowska
7 Bank Density, Population Density, and Economic Deprivation across the United States: Implications for Public Health Outcomes
?Scott W. Hegerty
PART 3: Pharmaceutical Industry: Innovation, Trade, and Company Performance
8 Healthcare Systems and Pharmaceutical Industry in Emerging and Developed Economies: China and Poland versus the US and the EU
?Arkadiusz Michal Kowalski
9 Export Patterns in Medical Products in the Times of the Covid-19 Pandemic: Focus on Pharmaceuticals
?Marzenna Anna Weresa
10 Pharmaceutical Companies as Portfolio Investments
?Izabela Pruchnicka-Grabias
Conclusions
?Marzenna Anna Weresa, Christina Ciecierski and Lidia Filus
Index
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
America; E.U.; EU; European Union; Poland; U.S.; US; United States; cancer; cancer epidemiology; epidemiology; food; food safety; healthcare; healthcare system; medical products; pharmaceutical; pharmaceutical industry; pharmaceutics; public health; risk factors for cancer; safety; social determinants of health; zoonotic; zoonotic diseases
